Elanco Animal Health (ELAN) Cost of Revenue (2017 - 2026)

Elanco Animal Health has disclosed Cost of Revenue across 10 years of filings, most recently posting $586.0 million for Q1 2026.

• Cost of Revenue for Q1 2026 came in at $586.0 million, up 15.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.2 billion (up 10.12% YoY), and the FY2025 annual result was $2.1 billion, up 5.94% from the prior year.
• Cost of Revenue came in at $586.0 million for Q1 2026 at Elanco Animal Health, up from $555.0 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $586.0 million in Q1 2026 to a low of $434.0 million in Q2 2023.
• The 5-year median for Cost of Revenue is $501.0 million (2024), against an average of $503.2 million.
• Across the five-year window, Cost of Revenue declined 12.16% in 2022 and advanced 15.18% in 2023, its largest moves.
• Elanco Animal Health's Cost of Revenue stood at $448.0 million in 2022, then rose by 15.18% to $516.0 million in 2023, then slipped by 2.91% to $501.0 million in 2024, then climbed by 10.78% to $555.0 million in 2025, then increased by 5.59% to $586.0 million in 2026.
• The last three Cost of Revenue figures came in at $586.0 million (Q1 2026), $555.0 million (Q4 2025), and $530.0 million (Q3 2025), per Business Quant data.